Your Article Summary
Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells
Leukemia and Lymphoma, 07/02/09
Kim SW et al. - Incubation of cells under hypoxic conditions (1% O2) also induced upregulation of CXCR4 in the cytoplasm and on the cell surface and enhanced chemotaxis in response to stromal cell-derived factor-1 (SDF-1). Cell surface CXCR4 expression was more prominent in annexin V-positive apoptotic cells. Given the roles of the SDF-1/CXCR4 axis in the development and progression of myeloma, CXCR4-downregulating agents may enhance the antitumor effects of dexamethasone.
Related Articles
Multiple myeloma and cutaneous anaplastic large T-cell lymphoma in the same patient: Is there a causal relation
Journal of Cutaneous Pathology, 11/09/09
Relevance Score: 67%
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma
Investigational New Drugs, 10/23/09
Relevance Score: 67%
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
American Journal of Hematology, 11/10/09
Relevance Score: 66%
Primary plasma cell leukemia
Cancer, 11/04/09
Relevance Score: 66%
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Cancer Cell, 10/12/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/04/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of striae distensae with a TriPollar radiofrequency device: A pilot study
Journal of Dermatological Treatment , 12/04/09
Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: A randomized clinical study
Journal of Dermatological Treatment , 12/04/09
Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: A novel finding with important therapeutic implications
Journal of Dermatological Treatment , 12/04/09

See Latest Articles